ARDELYX, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- ARDELYX, INC. payments for repurchase of common stock for the quarter ending 2013-12-31 was $0.00.
- ARDELYX, INC. payments for repurchase of common stock for the quarter ending 2013-09-30 was $0.00.
- ARDELYX, INC. payments for repurchase of common stock for fiscal 2014 was $2.00K, a 0.00% change from fiscal 2013.
- ARDELYX, INC. payments for repurchase of common stock for fiscal 2013 was $2.00K, a 90.00% decline from fiscal 2012.
- ARDELYX, INC. payments for repurchase of common stock for fiscal 2012 was $20.00K.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2014-12-31 | $2.00K 10-K · filed 2015-03-05 | |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-05 | $2.00K 10-K · filed 2015-03-05 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | |
| 2012-12-31 | $20.00K 10-K · filed 2015-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |